CHA 2 DS 2 -VASc score use in sinus rhythm: Can it predict cardiovascular events?

Abstract

Get full access to this article

View all access options for this article.

References

Kirchhof

Benussi

Kotecha

, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893–2962.

Proietti

Farcomeni

Romiti

, et al. Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients. Eur J Prev Cardiol. Epub ahead of print 6 December 2018; DOI: 10.1177/2047487318817662.

Xing

Sun

, et al. CHA₂DS₂-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation. Clin Interv Aging 2018; 13: 497–504.

Baturova

Lindgren

Carlson

, et al. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke. Int J Cardiol 2015; 199: 248–252.

Sciacqua

Perticone

Tripepi

, et al. CHADS₂ and CHA₂DS²-VASc scores are independently associated with incident atrial fibrillation: The Catanzaro Atrial Fibrillation Project. Intern Emerg Med 2015; 10: 815–821.

Renda

Ricci

Patti

, et al. CHA₂DS₂-VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation. Eur J Prev Cardiol. 2019; 26: 1987–1997.

Aune

Schlesinger

Norat

, et al. Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 2018; 25: 1437–1451.

Diener

H-C

Sacco

Easton

, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 2019; 380: 1906–1917.